Science Blog: How Is AI Drug Discovery Doing, Really?
AnodicElegy · hn · 2026-08-16
This in-depth blog post from Science analyzes the current state of AI in drug discovery. It highlights the success of AI models like AlphaFold 2 in protein structure prediction and their impact on early-stage discovery workflows. However, it also outlines significant challenges: generated molecules are often difficult to synthesize and lack diversity, while clinical trial failure rates remain high. The author concludes that AI has potential but is not a magic bullet, emphasizing the need for better data quality and validation methods.
More from Research
- BM25 remains competitive in RAG benchmarks; ColBERT outperforms larger LLMs — antoine_chaffin · 2026-08-16
- Opus 5 test reveals models understand objects deeply but lack novelty — scaling01 · 2026-08-16
- 18-Model AI Research Experiment: Fable 5 Closes 82% of Human Gap — eliebakouch · 2026-08-16
- Pose Resolution Architecture: Exploring Drive and Curiosity in Online Learning Systems — Calmera · 2026-08-16
- Microsoft study: Agent skills can be harmful, 307 failures reveal pitfalls — coallaoh · 2026-08-16
- Meta Paper: Scaling Laws Hold in Tiny Models — ChengleiSi · 2026-08-16